(Gene Therapy)
Michelle Hylan serves as Head of Clinical Operations and is an internationally experienced Clinical Research Executive with demonstrated success partnering with clients to optimize clinical program outcomes through alignment of business strategy, processes, and org composition, as well as bringing biotech start-ups from proof of concept to IPO. Michelle has focused on advancing unique science solutions to address unmet medical needs. She has broad experience in industry best practices on global programs, clinical, and quality management. She specializes in strategic development and implementation, clinical trial design, CRO/vendor selection and management
(Gene Therapy)
(Canavan Disease)